EVEROLIMUS

Generic: EVEROLIMUS

Amneal Pharmaceuticals NY LLCManufacturer
ORALRoute
EVEROLIMUSActive Substance
2025-01-10Original Approval

EVEROLIMUS is FDA application ANDA218863, sponsored by AMNEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
MALIGNANT NEOPLASM PROGRESSION
1,592 reports
2
OFF LABEL USE
1,375 reports
3
DIARRHOEA
1,255 reports
4
DRUG INEFFECTIVE
1,021 reports
5
FATIGUE
863 reports
6
NAUSEA
782 reports
7
DEATH
766 reports
8
DISEASE PROGRESSION
758 reports
9
PRODUCT USE IN UNAPPROVED INDICATION
755 reports
10
DYSPNOEA
664 reports